Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Kappa-type opioid receptor | ||
Ligand | BDBM50100464 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_145836 (CHEMBL755494) | ||
Ki | 32.7±n/a nM | ||
Citation | Sharma, SK; Jones, RM; Metzger, TG; Ferguson, DM; Portoghese, PS Transformation of a kappa-opioid receptor antagonist to a kappa-agonist by transfer of a guanidinium group from the 5'- to 6'-position of naltrindole. J Med Chem44:2073-9 (2001) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
Kappa-type opioid receptor | |||
Name: | Kappa-type opioid receptor | ||
Synonyms: | KOR-1 | Kappa Opioid Receptor | OPIATE Kappa | OPRK_RAT | Opioid receptor | Oprk1 | Ror-d | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 42692.90 | ||
Organism: | Rattus norvegicus (rat) | ||
Description: | P34975 | ||
Residue: | 380 | ||
Sequence: |
| ||
BDBM50100464 | |||
n/a | |||
Name | BDBM50100464 | ||
Synonyms: | 7`-guanidino-17-(cyclopropylmethyl)-6,7-didehydro-4,5alpha-epoxy-3,14-hydroxyindolo-[2`,3`:6,7]morphinian | ||
Type | Small organic molecule | ||
Emp. Form. | C27H29N5O3 | ||
Mol. Mass. | 471.5509 | ||
SMILES | NC(N)=Nc1cccc2c3C[C@@]4(O)C5Cc6ccc(O)c7O[C@@H](c3[nH]c12)[C@]4(CCN5CC1CC1)c67 |wU:11.11,wD:26.39,22.21,THB:20:34:11:29.27.28,16:15:11:29.27.28,(17.3,-18.58,;16.66,-19.98,;17.55,-21.24,;15.13,-20.12,;14.24,-18.86,;14.87,-17.48,;14,-16.22,;12.47,-16.36,;11.84,-17.76,;10.38,-18.21,;9.06,-17.41,;7.72,-18.16,;8.12,-16.67,;6.39,-17.38,;5.05,-18.14,;5.04,-19.68,;3.72,-20.45,;3.72,-21.99,;5.04,-22.76,;5.04,-24.3,;6.37,-21.99,;8.59,-21.98,;9.01,-20.49,;10.36,-19.75,;11.81,-20.24,;12.72,-19,;7.68,-19.7,;5.72,-18.42,;5.32,-16.92,;6.42,-15.84,;5.09,-15.06,;5.09,-13.52,;4.32,-12.18,;5.88,-12.19,;6.37,-20.45,)| | ||
Structure |